ID   KCB10
AC   CVCL_D3ZK
DR   Wikidata; Q127382411
RX   PubMed=32144432;
RX   PubMed=34275013;
CC   Population: Japanese.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
RX   PubMed=32144432; DOI=10.1007/s00280-020-04045-9;
RA   Goto, Hiroaki
RA   Yoshino, Yuki
RA   Ito, Mieko
RA   Nagai, Jun-ichi
RA   Kumamoto, Tadashi
RA   Inukai, Takesi
RA   Sakurai, Yukari
RA   Miyagawa, Naoyuki
RA   Keino, Dai
RA   Yokosuka, Tomoko
RA   Iwasaki, Fuminori
RA   Hamanoue, Satoshi
RA   Shiomi, Masae
RA   Goto, Shoko
RT   "Aurora B kinase as a therapeutic target in acute lymphoblastic
RT   leukemia.";
RL   Cancer Chemother. Pharmacol. 85:773-783(2020).
//
RX   PubMed=34275013; DOI=10.1007/s00280-021-04321-2;
RA   Goto, Hiroaki
RA   Yoshino, Yuki
RA   Ito, Mieko
RA   Nagai, Jun-ichi
RA   Kumamoto, Tadashi
RA   Inukai, Takesi
RA   Sakurai, Yukari
RA   Miyagawa, Naoyuki
RA   Keino, Dai
RA   Yokosuka, Tomoko
RA   Iwasaki, Fuminori
RA   Hamanoue, Satoshi
RA   Shiomi, Masae
RA   Goto, Shoko
RT   "Correction to: Aurora B kinase as a therapeutic target in acute
RT   lymphoblastic leukemia.";
RL   Cancer Chemother. Pharmacol. 88:1055-1056(2021).
//